Cyclacel Pharmaceuticals Inc (CYCC)
2.27
-0.04
(-1.73%)
USD |
NASDAQ |
May 10, 16:00
2.27
0.00 (0.00%)
After-Hours: 19:43
Cyclacel Pharmaceuticals Cash from Operations (TTM): -16.11M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -16.11M |
| September 30, 2023 | -17.37M |
| June 30, 2023 | -20.30M |
| March 31, 2023 | -20.91M |
| December 31, 2022 | -20.83M |
| September 30, 2022 | -20.21M |
| June 30, 2022 | -19.45M |
| March 31, 2022 | -21.75M |
| December 31, 2021 | -18.54M |
| September 30, 2021 | -15.14M |
| June 30, 2021 | -11.06M |
| March 31, 2021 | -8.693M |
| December 31, 2020 | -7.934M |
| September 30, 2020 | -7.899M |
| June 30, 2020 | -7.781M |
| March 31, 2020 | -8.57M |
| December 31, 2019 | -9.447M |
| September 30, 2019 | -10.37M |
| June 30, 2019 | -9.078M |
| March 31, 2019 | -8.246M |
| December 31, 2018 | -6.701M |
| September 30, 2018 | -6.885M |
| June 30, 2018 | -7.411M |
| March 31, 2018 | -5.809M |
| December 31, 2017 | -7.48M |
| Date | Value |
|---|---|
| September 30, 2017 | -8.203M |
| June 30, 2017 | -9.907M |
| March 31, 2017 | -10.74M |
| December 31, 2016 | -10.08M |
| September 30, 2016 | -9.812M |
| June 30, 2016 | -10.96M |
| March 31, 2016 | -12.71M |
| December 31, 2015 | -14.46M |
| September 30, 2015 | -15.45M |
| June 30, 2015 | -17.55M |
| March 31, 2015 | -18.88M |
| December 31, 2014 | -18.70M |
| September 30, 2014 | -20.41M |
| June 30, 2014 | -16.34M |
| March 31, 2014 | -17.56M |
| December 31, 2013 | -18.20M |
| September 30, 2013 | -15.28M |
| June 30, 2013 | -15.25M |
| March 31, 2013 | -13.64M |
| December 31, 2012 | -12.04M |
| September 30, 2012 | -12.84M |
| June 30, 2012 | -13.00M |
| March 31, 2012 | -13.86M |
| December 31, 2011 | -13.98M |
| September 30, 2011 | -14.46M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-21.75M
Minimum
Mar 2022
-7.781M
Maximum
Jun 2020
-14.29M
Average
-15.14M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
| Corvus Pharmaceuticals Inc | -23.94M |
| Oragenics Inc | -7.291M |
| Relmada Therapeutics Inc | -51.66M |
| Alpine Immune Sciences Inc | -79.01M |
| MAIA Biotechnology Inc | -13.07M |